Stockscreener 앱 받기
1.2279
2.23%
0.0268
전일 마감가:
$1.2011
열려 있는:
$1.21
하루 거래량:
2,328
Relative Volume:
0.23
시가총액:
$3.60M
수익:
$5.31M
순이익/손실:
$-2.90M
주가수익비율:
-0.8266
EPS:
-1.4855
순현금흐름:
$-1.18M
1주 성능:
-6.98%
1개월 성능:
-21.79%
6개월 성능:
-46.14%
1년 성능:
-76.34%
1일 변동 폭
$0.00
$0.00
1주일 범위
$1.19
$1.2827
52주 변동 폭
$1.07
$5.8876
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
명칭
Bionexus Gene Lab Corp
전화
1-307-241-6898
주소
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Compare BGLC vs LIN, SHW, ECL, APD, PPG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BGLC
Bionexus Gene Lab Corp
|
1.2279 | 3.60M | 5.31M | -2.90M | -1.18M | -1.4855 |
LIN
Linde Plc
|
503.44 | 232.08B | 34.66B | 7.25B | 5.10B | 15.07 |
SHW
Sherwin Williams Co
|
331.61 | 80.50B | 23.94B | 2.60B | 2.91B | 10.42 |
ECL
Ecolab Inc
|
285.94 | 80.16B | 16.45B | 2.12B | 1.87B | 7.3955 |
APD
Air Products Chemicals Inc
|
298.65 | 66.51B | 12.46B | 2.16B | -1.25B | 9.454 |
PPG
Procter Gamble Co
|
107.55 | 23.91B | 16.12B | 1.59B | 1.23B | 6.9799 |
Bionexus Gene Lab Corp 주식(BGLC)의 최신 뉴스
BioNexus to Build AI Applications for Malaysian Healthcare Under Exclusive CogniAI Licence - FinancialContent
Ruanyun Edai Technology Announces Definitive Agreement to License Cogni AI to BioNexus Gene Lab for Malaysian Healthcare Market - Quiver Quantitative
RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab - GlobeNewswire Inc.
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
12 Industrials Stocks Moving In Friday's Pre-Market Session - Benzinga
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
11 Industrials Stocks Moving In Wednesday's After-Market Session - Benzinga
Jook Yuen Low Net Worth (2026) - GuruFocus
Set Fui Chong Net Worth (2026) - GuruFocus
Fidelion Diagnostics Pte. Ltd. Net Worth (2026) - GuruFocus
Bin Abdul Hamid Muhammad Azrul Net Worth (2026) - GuruFocus
BioNexus Gene Lab Revenue Collapses 97% in Q2 as Major Customer Lost - minichart.com.sg
BioNexus Gene Lab Corp (BGLC) CEO reports 338,709-share award and 11.5% stake - Stock Titan
BioNexus Gene Lab Corp (BGLC) grants CEO 338,709 fully vested shares - Stock Titan
BioNexus Gene Lab Corp (BGLC) director receives 32,258-share fully vested award - Stock Titan
BioNexus Gene Lab Corp (BGLC) director receives 32,258-share equity award - Stock Titan
BioNexus Gene Lab Corp (BGLC) CFO receives 96,774-share equity award - Stock Titan
BioNexus Gene Lab Corp (BGLC) director granted 16,129-share fully vested stock award - Stock Titan
BioNexus Gene Lab Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
BioNexus Gene Lab files initial beneficial ownership statement for Fidelion Diagnostics Pte. Ltd - Bitget
Fidelion Diagnostics reports 392,329 BioNexus Gene Lab Corp (NASDAQ: BGLC) shares - Stock Titan
BioNexus Gene Lab Corp (BGLC) Stock News Today - TradingKey
BioNexus Gene Lab Corp (BGLC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioNexus Gene Lab files initial beneficial ownership statement for Fidelion Diagnostics Pte. Ltd - Bitget
BioNexus Gene Lab (BGLC) Surges 8.3% to $1.43: Can Momentum Break the $1.50 Ceiling?Volume Climax - dars.gov.et
BioNexus Gene Lab (BGLC) director discloses 1,261 common shares in Form 3 - Stock Titan
BioNexus Gene Lab (BGLC) director files Form 3 with zero shares - Stock Titan
BioNexus Gene Lab Corp (BGLC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BioNexus Says VitaGuard Blood Tests Could Cost Under $300 - Stock Titan
BioNexus Advances VitaGuard™ Southeast Asia Rollout Following China Working Visit - GlobeNewswire
BGLC|BioNexus Gene Lab Corp|Price:1.370|Chg%:-0.140 - TradingKey
BGLC|BioNexus Gene Lab Corp|Price:1.450|Chg%:-0.060 - TradingKey
BioNexus Gene Lab Corp Revenue Breakdown – NASDAQ:BGLC - TradingView
BioNexus Gene Lab Corp (BGLC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioNexus Gene Lab Corp (BGLC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BGLC|BioNexus Gene Lab Corp|Price:1.510|Chg%:-0.050 - TradingKey
BioNexus Gene Lab Corp (BGLC) Cash Flow - TradingKey
TradingKey - TradingKey
BioNexus Gene Lab Corp (BGLC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BioNexus Gene Lab Corp (BGLC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BGLC|BioNexus Gene Lab Corp|Price:1.613|Chg%:-0.027 - TradingKey
BioNexus Gene Lab Corp (BGLC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bionexus Gene Lab Corp (BGLC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
8.21%
2.46%
자본화:
|
볼륨(24시간):